SERTRALINE INFLUENCE ON MORPHINE-INDUCED CONDITIONED PLACE PREFERENCE IN RATS

Authors

  • Diana CIUBOTARIU University of Medicine and Pharmacy “Grigore T. Popa” - Iaşi
  • M. NECHIFOR University of Medicine and Pharmacy “Grigore T. Popa” - Iaşi

Abstract

Serotonine reuptake inhibitors are an important pharmacological arsenal for treating major depression, a severe disease with poorly understood pathogenic mechanisms. Also, little is known about the action of antidepressants on reward system, the function of which is severely affected in this disorder. Aim: To assess the influence of sertraline on brain reward system by conditioned place preference technique in rats. Results: Both 3 and 5 mg/kg doses of sertraline determined a significant rewarding effect, whereas only the 5 mg/kg dose increased the morphine-induced rewarding effect (in the morphine-only group time spent in the conditioning chamber increased by 184.92±21.43% post-conditioning vs. pre-conditioning, whereas the increase was 195.56±18.3% in the group treated with morphine and sertraline 5mg/kg, p<0.05). Conclusions: The stimulant effect of sertraline on brain reward function might be involved in its therapeutic efficacy.

Author Biographies

  • Diana CIUBOTARIU, University of Medicine and Pharmacy “Grigore T. Popa” - Iaşi

    Faculty of Dental Medicine
    Discipline of  Pharmacology

  • M. NECHIFOR, University of Medicine and Pharmacy “Grigore T. Popa” - Iaşi

    Faculty of Dental Medicine
    Discipline of  Pharmacology

References

1. Muijsers RB, Plosker GL, Noble S. Sertraline: a review of its use in the management of major depres-sive disorder in elderly patients. Drugs Aging. 2002; 19: 377-392.
2. Inoue T, Honda M, Kawamura K et al. Sertraline treatment of patients with major depressive disorder who failed initial treatment with paroxetine or fluvoxamine. Prog Neuropsychopharmacol Biol Psy-chiatry. 2012; 38: 223-227.
3. Bourgeois J, Elseviers MM, Van Bortel L, Petrovic M, Vander Stichele RH. The use of antidepressants in Belgian nursing homes: focus on indications and dosages in the PHEBE study. Drugs Aging. 2012; 29: 759-769.
4. Phan KL, Coccaro EF, Angstadt M et al. Corticolimbic brain reactivity to social signals of threat before and after sertraline treatment in generalized social phobia. Biol Psychiatry. 2013; 73: 329-336.
5. Andrisano C, Chiesa A, Serretti A. Newer antidepressants and panic disorder: a meta-analysis. Int Clin Psychopharmacol. 2013; 28: 33-45.
6. Kitaichi Y, Inoue T, Nakagawa S et L. Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats. Eur J Pharmacol. 2010; 647: 90-96.
7. Tzschentke TM. Reassessment of buprenorphine in conditioned place preference: temporal and phar-macological considerations. Psychopharmacol. 2004; 172: 58-67.
8. van der Kooy D, Fishell G. Neuronal birthdate underlies the development of striatal chambers. Brain Res. 1987; 401: 155-161.
9. Bardo MT, Bevins RA. Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacol. 2000; 153: 31-43.
10. Bagdy G, Graf M, Anheuer ZE, Modos EA, Kantor S. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Int J Neuropsychopharmacol. 2001; 4: 399-408.
11. Kurt M, Arik AC, Celik S. The effects of sertraline and fluoxetine on anxiety in the elevated plus-maze test in mice. J Basic Clin Physiol Pharmacol. 2000; 11: 173-180
12. Subhan F, Deslandes PN, Pache DM, Sewell RD. Do antidepressants affect motivation in conditioned place preference? Eur J Pharmacol. 2000; 408: 257-263.

Additional Files

Published

2018-04-29